Page last updated: 2024-10-31

metoprolol and Central Serous Chorioretinopathy

metoprolol has been researched along with Central Serous Chorioretinopathy in 1 studies

Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.

Central Serous Chorioretinopathy: A visual impairment characterized by the accumulation of fluid under the retina through a defect in the retinal pigment epithelium.

Research Excerpts

ExcerptRelevanceReference
"To investigate ocular safety of intravitreal metoprolol in eyes with central serous chorioretinopathy."8.12Safety of intravitreal metoprolol in eyes with central serous chorioretinopathy. ( Chaves, L; de Azeredo Bastos, TM; Gonçalves, AN; Jorge, R; Messias, A, 2022)
"To investigate ocular safety of intravitreal metoprolol in eyes with central serous chorioretinopathy."4.12Safety of intravitreal metoprolol in eyes with central serous chorioretinopathy. ( Chaves, L; de Azeredo Bastos, TM; Gonçalves, AN; Jorge, R; Messias, A, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Gonçalves, AN1
Messias, A1
Chaves, L1
de Azeredo Bastos, TM1
Jorge, R1

Other Studies

1 other study available for metoprolol and Central Serous Chorioretinopathy

ArticleYear
Safety of intravitreal metoprolol in eyes with central serous chorioretinopathy.
    Documenta ophthalmologica. Advances in ophthalmology, 2022, Volume: 145, Issue:3

    Topics: Central Serous Chorioretinopathy; Electroretinography; Fluorescein Angiography; Humans; Intravitreal

2022